The ENHANCE study and marketing ezetimibe.
Fatima
F
Akdim
John J P
JJ
Kastelein
Daniel
D
Gaudet
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D001384:Azetidines / Q000627:therapeutic use*; D000069438:Ezetimibe; D006801:Humans; D006938:Hyperlipoproteinemia Type II / Q000188:drug therapy*
D000924:Anticholesteremic Agents; D001384:Azetidines; D000069438:Ezetimibe